# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 26일


## 주요 헤드라인

1. **Avidity Played Hardball to Land Favorable Terms in $12B Novartis Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/avidity-played-hardball-to-land-favorable-terms-in-12b-novartis-deal>

2. **Avidity Played Hardball to Land Favorable Terms in $12B Novartis Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/avidity-played-hardball-to-land-favorable-terms-in-12b-novartis-deal>

3. **Novo Bounces Back With ‘Competitive’ Mid-Stage Weight Loss Data for Amycretin (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novo-bounces-back-with-competitive-mid-stage-weight-loss-data-for-amycretin>

4. **Lilly Redefines the Pharma Mega-Blockbuster (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-redefines-the-pharma-mega-blockbuster>

5. **ASH25 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/late-stage-data-for-j-js-tecvayli-darzalex-combo-could-shift-paradigm-in-myeloma>

6. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-cell-and-gene-therapy-will-transform-lives-if-we-let-it>

7. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-cell-and-gene-therapy-will-transform-lives-if-we-let-it>


---
*2025년 11월 26일 바이오스페이스 뉴스 피드에서 생성된 리포트*